Genenta Science S.p.A.
GNTA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001838716
No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.
Holders of 5% or more of GNTA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Genenta Science S.p.A., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nuzzo Marco | 13D | 23.00%5.43M shares | New | May 5, 20261 filing | May 5, 2026 | SEC |
| Pierluigi Paracchi | 13G/A | 9.80%2.30M shares | −2.80 ppfrom 12.60% | Feb 10, 20252 filings | Jan 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Genenta Science S.p.A., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 5, 20264:39 PM ET | Nuzzo Marcoand 10 others | 13D | 23.00%5.43M shares | New | May 4, 2026 | SEC |
| Jan 27, 20266:08 AM ET | Pierluigi Paracchi | 13G/A | 9.80%2.30M shares | −2.80 ppfrom 12.60% | Jan 25, 2026 | SEC |
| Feb 10, 20254:05 PM ET | Pierluigi Paracchi | 13G/A | 12.60%2.30M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Genenta Science S.p.A. shares.
No Form 144 notices for Genenta Science S.p.A. are on file.